Question special
Lead Moderator

To start this discussion, I want to ask our panel for some added context to the CANTOS paper. Inflammation has long been implicated in cardiovascular disease. Moreover, a variety of anti-inflammatory drugs have been available for decades. Why has it taken so long to show such a direct connection between treating inflammation and reducing cardiovascular events?